NCT04687800View on ClinicalTrials.gov

Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery

PHASE4TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

October 24, 2022

Study Completion Date

October 24, 2022

Conditions

Cataract

Interventions

DRUG

Dextenza 0.4mg intracanalicular Insert

intracanalicular insert delivery system

DRUG

Durezol 0.05% Ophthalmic Emulsion

Standard therapy, topical steroid drop

Trial Locations (1)

34209

The Eye Associates of Manatee, Bradenton

Sponsors

Collaborators (1)

Ocular Therapeutix, Inc.

All Listed Sponsors

collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Cathleen McCabe MD

OTHER